Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Delaware court rejects activist's attempt to control CytoDyn's board

Published 10/14/2021, 01:55 PM
Updated 10/14/2021, 03:26 PM
© Reuters.

© Reuters.

By Svea Herbst-Bayliss

(Reuters) - The Delaware Chancery Court this week ruled that an activist investor's attempt to seize control of biotechnology firm CytoDyn (OTC:CYDY)'s board is invalid, marking a rare rebuke from a court that hears disputes over mergers and governance matters.

The court ruled that the activist group, which owns less than 1% of CytoDyn's stock, failed to comply with the company's bylaws and left out key information on a conflict of interest. "These omissions, in turn, left their Nomination Notice fatally incomplete," the ruling, dated October 13, said.

The activist group, led by Paul Rosenbaum, wrote to the company, which is working on coronavirus treatments, on June 30 to say it planned to nominate five directors to the company's six-member board. They say the board enabled operational failures and presided over a sharp share price drop.

"We believe strongly that the Court’s ruling is fundamentally flawed and, as such, we are evaluating all possible alternatives," the group said.

The company rejected the group's notice letter, saying it failed to comply with company bylaws and was riddled with errors ranging from mistakes in the nominees' standard questionnaires to failing to properly disclose the group's funding.

The company is being represented by law firms Sidley Austin LLP and Potter Anderson & Corroon LLP while the activists are being represented by Greenberg Traurig LLP and Baker Botts LLP.

After the company rejected the nomination, the matter moved to the courts.

"Where the Plaintiffs ultimately went wrong here is by playing fast and loose with their responses to key inquiries embedded in the advance notice bylaw, the ruling said.

This is the first time a Delaware court has been asked to rule on a shareholder submitting a notice that failed to supply information mandated by the company's bylaws.

The company is valued at roughly $1 billion and its stock price dropped 13.7% to $1.36 on Thursday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.